Notoginsenoside Fc( —— )

Catalog No. M19221 CAS No. 88122-52-5

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Group Booking Get Quotation Bulk Inquiry Add to Cart

Product Name

Notoginsenoside Fc
Note

Research use only, not for human use.
Brief Description

Notoginsenoside Fc has perfect anti-platelet aggregatory effect.
Description

Notoginsenoside Fc has perfect anti-platelet aggregatory effect.
In Vitro

Notoginsenoside Fc (20 μM; for 24?h) markedly upregulates the expression of LC3B and Beclin 1 and downregulated that of p62 in RAOECs.
In Vivo

Notoginsenoside Fc (3.5?mg/kg/day) accelerates reendothelialization and alleviates excessive neointimal formation following carotid artery injury in diabetic Sprague-Dawley rats (200±20?g) in vivo.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

CAS Number

88122-52-5
Formula Weight

1211.38
Molecular Formula

C58H98O26
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 100 mg/mL (82.55 mM)
SMILES

CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(CO7)O)O)O)C)C)O)C)OC8C(C(C(C(O
Chemical Name

——